Cylert Letter to Health Professionals FDA (Health/Medications)
fda.gov

Description: Reproduction of warning letter sent by Abbott Labs to Health Professionals regarding potential for hepatotoxicity with Cylert. Includes link to patient informationconsent form. Cylert (pemoline)recommendations for liver function monitoring

Specializes in: cylert pemoline liver function monitoring postmarketing surveillance adverse reactions medwatch fda medical product safety

Website owner:

Unavailable